GPX4 and cancer: Another study reported ferroptosis inducers (FINs) such as sorafenib, RSL3, sulfasalazine, and erastin, synergistically increased the effect of radiotherapy in various cancers, including melanoma, by reducing SLC7A11 expression or inhibiting GPX4 [116].